WAKEFIELD, Mass., Feb. 10, 2022 /PRNewswire/ — MMJ BioPharma Labs recently became one of the only federally authorized labs dedicated to cannabis extraction, research, and development with their approved DEA Analytical Lab Registration for schedule 1-4 drugs. MMJ BioPharma’s primary focus is on cannabis research and development. MMJ BioPharma Labs will be assisting MMJ International Holdings in the research and development of its proprietary gel cap medicine, for the eventual FDA approval of its medicines MMJ 001 and MMJ 002 to treat Multiple Sclerosis and Huntington’s Disease. Clinical trials will begin soon.
Wakefield, MA based STEM Solutions, LLC., a nationwide provider of commercial and educational institution laboratory equipment and casework outfitted the lab. STEM Solutions built the lab in record time amidst industry-wide supply shortages. “MMJ BioPharma Labs leveraged our in-stock program of laboratory casework and our partnerships with FunderMax and JHC Fabrication to expedite the phenolic tops to build the lab in four weeks,” said Ed St. Peter, Managing Member at STEM.
“Early in the process, STEM Solutions visited our facility and said if we do A, B, and C, we can get it up and running in your timeframe,” said Duane Boise, President of MMJ. “Now, through their commitment and hard work we have an MMJ BioPharma Lab that is a true center of excellence to advance the science of medical cannabis,” he continued.
MMJ BioPharma Labs had to adhere to very strict DEA inspections and agreed upon guidelines for approval. With this DEA registration, MMJ BioPharma Labs can manufacture, transport, import, and export cannabis domestically and internationally to DEA registrants and companies registered in their respective international jurisdictions.
The MMJ BioPharma lab will foster and conduct scientific research, data analysis, education, and training on the health effects of cannabis. MMJ BioPharma Labs researchers and leaders could aid in policymaking and outreach as state programs emerge.
“There is no doubt that cannabis can provide treatments for serious diseases, and there is a solid research foundation for further exploration,” said Dr. Elio Mariani, longtime pharma veteran and MMJ’s CEO. “The potency of the plant, the sophistication of the labs preparation and delivery method all lead to delivering its many health benefits to patients in need.”
About STEM Solutions LLC
STEM Solutions LLC., is the leading provider of commercial and educational custom lab fit outs in the United States. For more information, please visit: https://www.labfitout.com/
PRESS CONTACT:
Cori DiDonato
781-214-3808
https://www.silvertigerconsulting.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/stem-solutions-llc-builds-federally-authorized-cannabis-lab-for-mmj-biopharma-labs-301478930.html
SOURCE STEM Solutions LLC
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq:…
NEW YORK, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed”…
Proposed merger would add a differentiated Phase 3 TROP2 Antibody-drug Conjugate (ADC) to the combined…
HALF-YEAR FINANCIAL REPORT AS OF JUNE 30, 2024 December 27, 2024, 6.00 p.m. Safe Group announces…
GRANTS, NEW MEXICO, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC: BGXX) (“Bright…
BOSTON, Dec. 27, 2024 /PRNewswire/ -- Judge Baker Children's Center d/b/a The Baker Center for…